cisatracurium besylate

Sandoz Inc🇺🇸 United States

FDA Page

Effective Date: Nov 7, 2022
Approval ID: 2ee0358e-2cce-40d3-9fcf-1b9088815c98
Products: 1 registered
Version: 5

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use CISATRACURIUM BESYLATE INJECTION safely and effectively. See full prescribing information for CISATRACURIUM BESYLATE INJECTION.CISATRACURIUM BESYLATE injection, for intravenous useInitial U.S. Approval: 1995

Quick Stats

Total Products1

Labelers2

Label Sections16

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.